Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen synthesis via fibroblast stimulation describes the biological process in which fibroblasts, the primary mesenchymal cells responsible for producing extracellular matrix (ECM), are activated through signaling pathways such as TGF-β, JAK/STAT, PI3K, ERK, and AMPK to upregulate collagen gene transcription and subsequent collagen biosynthesis. This process is essential for tissue repair, wound healing, and maintaining skin integrity, but excessive activation can result in pathological fibrosis and contribute to tumor progression via the activity of cancer-associated fibroblasts (CAFs). Drugs can modulate these pathways to either promote or inhibit collagen deposition depending on therapeutic need.
Inhibition or stimulation of upstream signaling pathways (TGF-β, JAK/STAT, PI3K, ERK, AMPK) that regulate fibroblast function and thus collagen synthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen synthesis mediated by fibroblast activation (null).